HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Submit a Letter to Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Leff, M. A. Articles by Hein, D. W. Search for Related Content PubMed PubMed Citation Articles by Leff, M. A. Articles by Hein, D. W. Social Bookmarking                      What's this?

J Biol Chem, Vol. 274, Issue 49, 34519-34522, December 3, 1999

COMMUNICATION
Novel Human N-Acetyltransferase 2 Alleles That Differ in Mechanism for Slow Acetylator Phenotype

From the Department of Pharmacology and Toxicology, University of Louisville School of Medicine, Louisville, Kentucky 40292

Three novel human NAT2 alleles (NAT2*5D, NAT2*6D, and NAT2*14G) were identified and characterized in a yeast expression system. The common rapid (NAT2*4) and slow (NAT2*5B) acetylator human NAT2 alleles were also characterized for comparison. The novel recombinant NAT2 allozymes catalyzed both N- and O-acetyltransferase activities at levels comparable with NAT2 5B and significantly below NAT2 4, suggesting that they confer slow acetylation phenotype. In order to investigate the molecular mechanism of slow acetylation in the novel NAT2 alleles, we assessed mRNA and protein expression levels and protein stability. No differences were observed in NAT2 mRNA expression among the novel alleles, NAT2*4 and NAT2*5B. However NAT2 5B and NAT2 5D, but not NAT2 6D and NAT2 14G protein expression were significantly lower than NAT2 4. In contrast, NAT2 6D was slightly (3.4-fold) and NAT2 14G was substantially (29-fold) less stable than NAT2 4. These results suggest that the 341T  C (Ile¹¹⁴  Thr) common to the NAT2*5 cluster is sufficient for reduction in NAT2 protein expression, but that mechanisms for slow acetylator phenotype differ for NAT2 alleles that do not contain 341T  C, such as the NAT2*6 and NAT2*14 clusters. Different mechanisms for slow acetylator phenotype in humans are consistent with multiple slow acetylator phenotypes.

CiteULike

Complore

Connotea

Del.icio.us

Digg

Reddit

Technorati

This article has been cited by other articles:

				F. A. Jefferson, G. H. Xiao, and D. W. Hein 4-Aminobiphenyl Downregulation of NAT2 Acetylator Genotype-Dependent N- and O-acetylation of Aromatic and Heterocyclic Amine Carcinogens in Primary Mammary Epithelial Cell Cultures from Rapid and Slow Acetylator Rats Toxicol. Sci., January 1, 2009; 107(1): 293 - 297. [Abstract] [Full Text] [PDF]

				Y. Zang, M. A. Doll, S. Zhao, J. C. States, and D. W. Hein Functional characterization of single-nucleotide polymorphisms and haplotypes of human N-acetyltransferase 2 Carcinogenesis, August 1, 2007; 28(8): 1665 - 1671. [Abstract] [Full Text] [PDF]

				M. Kinzig-Schippers, D. Tomalik-Scharte, A. Jetter, B. Scheidel, V. Jakob, M. Rodamer, I. Cascorbi, O. Doroshyenko, F. Sorgel, and U. Fuhr Should We Use N-Acetyltransferase Type 2 Genotyping To Personalize Isoniazid Doses? Antimicrob. Agents Chemother., May 1, 2005; 49(5): 1733 - 1738. [Abstract] [Full Text] [PDF]

				J. E. Summerscales and P. D. Josephy Human Acetyl CoA:Arylamine N-Acetyltransferase Variants Generated by Random Mutagenesis Mol. Pharmacol., January 1, 2004; 65(1): 220 - 226. [Abstract] [Full Text] [PDF]

				A. J. Fretland, U. S. Devanaboyina, M. A. Doll, S. Zhao, G. H. Xiao, and D. W. Hein Metabolic Activation of 2-Hydroxyamino-1-methyl-6-phenylimidazo[4,5-b]pyridine in Syrian Hamsters Congenic at the N-Acetyltransferase 2 (NAT2) Locus Toxicol. Sci., August 1, 2003; 74(2): 253 - 259. [Abstract] [Full Text] [PDF]

				S.-Y. Lee, K.-A Lee, C.-S. Ki, O. J. Kwon, H. J. Kim, M. P. Chung, G. Y. Suh, and J.-W. Kim Complete Sequencing of a Genetic Polymorphism in NAT2 in the Korean Population Clin. Chem., May 1, 2002; 48(5): 775 - 777. [Full Text] [PDF]

				C. Chen, S. Ricks, D. R. Doody, E.D. Fitzgibbons, P. L. Porter, and S. M. Schwartz N-Acetyltransferase 2 polymorphisms, cigarette smoking and alcohol consumption, and oral squamous cell cancer risk Carcinogenesis, December 1, 2001; 22(12): 1993 - 1999. [Abstract] [Full Text] [PDF]

				E. Sim, M. Payton, M. Noble, and R. Minchin An update on genetic, structural and functional studies of arylamine N-acetyltransferases in eucaryotes and procaryotes Hum. Mol. Genet., October 1, 2000; 9(16): 2435 - 2441. [Abstract] [Full Text] [PDF]

				D. W. Hein, M. A. Doll, A. J. Fretland, M. A. Leff, S. J. Webb, G. H. Xiao, U.-S. Devanaboyina, N. A. Nangju, and Y. Feng Molecular Genetics and Epidemiology of the NAT1 and NAT2 Acetylation Polymorphisms Cancer Epidemiol. Biomarkers Prev., January 1, 2000; 9(1): 29 - 42. [Abstract] [Full Text]